TR40 40mg*10vials

Tirzepatide TR40 40mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing an ultra-high-concentration metabolic research compound that activates two gut hormone pathways simultaneously.

The 40mg single-vial specification offers a very high active ingredient load per vial. This premium formulation is engineered for ultra-long-term large animal models, extreme high-dose efficacy comparison studies, and the largest-scale multi-group parallel research projects. The exceptionally high concentration per vial eliminates repeated dilution steps across very long experimental timelines, effectively reducing data deviation and sample contamination risk from frequent solution changes.

Through combined GLP-1 and GIP receptor activation, this compound supports comprehensive research into insulin sensitivity, glycemic regulation, appetite-related signaling, and long-term metabolic homeostasis. The dual pathway approach provides full-spectrum metabolic regulation research coverage across extended study durations.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for top-tier preclinical research institutions and large-scale global procurement.